EPISODE 093
Khalid Ishaque says Bioelectronic Medicine has made great strides in treating hearing loss, depression, and other maladies and shows great promise in treating neurological disorders like Alzheimer’s disease. Yet, most people still see it as more science fiction than science fact. But that’s changing. “What we are demonstrating with advances in miniaturization, imaging, and increased understanding of the cellular pathways and the brain is that what was once considered impossible is becoming possible,” he declares.
Overview: Pixium Vision is making great progress with its PRIMA subretinal implant.
Surprises: I thought the study was limited to Europe, but the company will be enrolling patients in Pittsburgh too.
Regrets: I wish I were running a “TransHuman: Innovation Summit”. Listen at the end of the podcast.
Enjoy the podcast!
Podcast Guest
Khalid Ishaque
CEO
PIXIUM VISION
Khalid Ishaque has over 20 years of experience in the medical technology sector. He joined Pixium Vision in 2014 after having spent 17 years with the Boston Scientific in various commercial and business development roles, and most recently as General Manager of International Neuromodulation division commercialising Spinal Cord and Deep Brain Stimulation systems for chronic pain and movement disorders. Before joining Boston Scientific in 1997, he worked for Becton Dickinson. He received his Master in engineering from Cranfield Institute of Technology in the United Kingdom and Master in international Economics and Management from SDA Bocconi University in Italy.
Meet Our Host
Geoff Pardo
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.